 |
|
|
 |
|
Rationale:
- Frequent return visits are essential to ensure proper wound healing and to evaluate for infectious complications.
- Follow-up of individuals being managed as outpatients can reinforce adherence with wound care and antibiotic therapy.
- Wounds closed primarily need to be assessed early for evidence of infection and to ensure removal of staples or sutures.
- Hand bites carry a high risk of infection, and it is imperative to identify infection early to lower morbidity.
- Early physical therapy decreases joint stiffness and improves functional status.
- Although rare, transmission of HIV and HBV through human bite wounds has been documented and needs to be confirmed serologically
in the months after a high-risk bite wound.
- Children who are victims of dog bites, especially when associated with multiple wounds, frequently have symptoms of posttraumatic
stress disorder months after the attack.
|
|
Evidence:
- A study of 30 consecutive patients with human facial bite injuries closed primarily revealed an infection rate of 10% (41).
- The rate of wound infection in 91 consecutive sutured dog bite wounds (57 head and neck, 16 upper extremity, 15 lower extremity,
3 trunk) was 4.4%, not significantly different but higher than the infection rate in nonrepaired wounds of 1.9%, according
to one prospective study of 734 consecutive dog bite victims presenting to an emergency department (37).
- A case report of HIV transmission from a human bite wound documented seroconversion 54 days after exposure following zidovudine
prophylaxis (73).
- A study of 22 childhood victims of dog bites showed that 12 had symptoms of posttraumatic stress disorder 2 to 9 months after
the bite (74).
|
|
Comments:
|
| FAQs |
|
|
|
Daniel G. Federman, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Jeffrey D. Kravetz, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|